A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.

Int J Colorectal Dis · 2012 · PMC3307993 · PMID 22130826

Europe PMC DOI

hedged sentences

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep = 0.10so close (0.05 < p ≤ 0.1)

At the end of the study, the difference between the groups (EcN 53.3%, placebo 41.7%) was 11.6% ([−6.1; 29.4]) and did not reach statistical significance ( p = 0.10).

also in 111,027 other papers

highly significantno p-value reported

Of particular interest are the highly significant effects on all qualities of pain such as intensity, duration and frequency.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.